Hughes Michael F, DeVito Michael J, Patlewicz Grace, Thomas Russell S, Adams Linda D, Ambroso Jeffrey L, Yang Xi, Upadhyay Bindu G, Burleson Stefanie C M, Kenyon Elaina M
Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Durham, NC 27709, USA.
RTI International, Durham, NC 27709, USA.
Toxics. 2025 Jun 10;13(6):490. doi: 10.3390/toxics13060490.
Some PFASs are immunotoxic in rodent models and associated with diminished vaccine response in exposed humans. This study assessed the immunotoxicity of four PFASs via the T cell-dependent IgM antibody response (TDAR) to sheep red blood cells (SRBCs) in adult male rats following 28-day oral repeat dosing. The PFASs included 1H,1H,9H-perfluorononyl acrylate (PFNAC), 1H,1H,2H,2H-perfluorohexyl iodide (PFHI), 2-chlorotetrafluoropropionic acid (CTFPA), and 3,3,4,4,5,5,5-heptafluoropentan-2-one (MHFPK), administered in corn oil. The positive control was cyclophosphamide (CPS). Rats were dosed with vehicle or PFAS from Days 0 to 27. On Day 22, an immunogenic dose of SRBCs was administered intravenously. Positive control animals were administered CPS by intraperitoneal injection from Days 22-27. On Day 28, the animals were euthanized; blood, thymus, and spleen samples were collected and weighed. Serum IgM was quantified by enzyme-linked immunosorbent assay. Body weights were unaffected in PFAS-treated rats, except for 3 and 10 mg/kg/day PFNAC-treated rats on Days 24, 27, and 28. Relative spleen and thymus weights and serum IgM levels were not affected by the PFASs at the doses tested, whereas CPS-treated animals had significant decreases in these parameters. The rat TDAR, as assessed by the anti-SRBC IgM response, was not affected by these four PFAS test agents following a 28-day oral exposure.
一些全氟和多氟烷基物质(PFASs)在啮齿动物模型中具有免疫毒性,并与接触人群疫苗反应减弱有关。本研究通过成年雄性大鼠口服重复给药28天后对绵羊红细胞(SRBCs)的T细胞依赖性IgM抗体反应(TDAR),评估了四种PFASs的免疫毒性。PFASs包括在玉米油中给药的丙烯酸1H,1H,9H-全氟壬酯(PFNAC)、1H,1H,2H,2H-全氟己基碘(PFHI)、2-氯四氟丙酸(CTFPA)和3,3,4,4,5,5,5-七氟戊-2-酮(MHFPK)。阳性对照为环磷酰胺(CPS)。大鼠在第0至27天接受赋形剂或PFAS给药。在第22天,静脉注射免疫原剂量的SRBCs。阳性对照动物在第22至27天通过腹腔注射给予CPS。在第28天,对动物实施安乐死;采集血液、胸腺和脾脏样本并称重。通过酶联免疫吸附测定法定量血清IgM。除了在第24、27和28天接受3和10 mg/kg/天PFNAC治疗的大鼠外,PFAS治疗的大鼠体重未受影响。在所测试的剂量下,PFASs对相对脾脏和胸腺重量以及血清IgM水平没有影响,而CPS治疗的动物这些参数显著降低。通过抗SRBC IgM反应评估的大鼠TDAR在口服暴露28天后不受这四种PFAS测试剂的影响。